Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 16 of 16 entries
View as:

Substance Balance Trial of Methoxyethyl Etomidate Hydrochloride

Phase: N/A Priority: Normal
NCT ID: NCT06822114 Org: User:
Start: 07/17/23 End: 07/31/23 Due: 07/31/24

Study of Efficacy, Safety, and Pharmacokinetics of FCN-437c in Combination With Fulvestrant or Letrozole+Goserelin

Phase: N/A Priority: Normal
NCT ID: NCT05004142 Org: User:
Start: 06/30/20 End: 06/30/23 Due: 06/30/24

This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c in Combination With Fluvestrant ± Goseraline Versus Placebo Combined With Fulvestrant ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT05438810 Org: User:
Start: 01/18/22 End: 05/18/24 Due: 05/18/25

This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT05439499 Org: User:
Start: 03/02/22 End: 03/02/25 Due: 03/02/26

A Trial to Evaluate the Efficacy and Safety of Methoxyetomidate Hydrochloride for Injection (ET-26) for the Induction of General Anesthesia in Elective Surgery Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06203431 Org: User:
Start: 10/11/23 End: 06/30/24 Due: 06/30/25

Phase 1 Hepatic Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride

Phase: N/A Priority: Normal
NCT ID: NCT06176716 Org: User:
Start: 12/06/23 End: 04/30/24 Due: 04/30/25

Clinical Trial of FCN-437c Capsule in Patients With Hepatic Insufficiency

Phase: N/A Priority: Normal
NCT ID: NCT06620731 Org: User:
Start: 09/04/23 End: 09/27/23 Due: 09/27/24

Safety, Tolerability, Pharmacokinetics and Antitumor Activity of FCN-437c

Phase: N/A Priority: Normal
NCT ID: NCT04488107 Org: User:
Start: 02/14/19 End: 06/30/22 Due: 06/30/23

Drug Interactions Trial of Methoxyethyl Etomidate Hydrochloride

Phase: N/A Priority: Normal
NCT ID: NCT06822166 Org: User:
Start: 12/04/23 End: 01/23/24 Due: 01/23/25

A Phase I Study of FCN-411 in Advanced Non-small Cell Lung Cancer Chinese Patients With EGFR Positive Mutation

Phase: N/A Priority: Normal
NCT ID: NCT03420079 Org: User:
Start: 08/01/18 End: 12/20/21 Due: 12/20/22

Clinical Study on Pharmacokinetics of FCN-437c Capsule and Its Effect on QT Interval in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06290466 Org: User:
Start: 11/11/22 End: 02/08/23 Due: 02/08/24

Safety and Pharmacokinetics/ Pharmacodynamics of Methoxyethyl Etomidate Hydrochloride in Healthy Elderly Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06764147 Org: User:
Start: 12/25/23 End: 02/02/24 Due: 02/02/25

Phase 1 Renal Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride

Phase: N/A Priority: Normal
NCT ID: NCT06747520 Org: User:
Start: 11/30/23 End: 02/28/24 Due: 02/28/25

A Clinical Trial to Evaluate the Efficacy and Safety of Methoxyethyl Etomidate Hydrochloride for Sedation/Anesthesia During Gastroscopy/Colonoscopy

Phase: N/A Priority: Normal
NCT ID: NCT06858852 Org: User:
Start: 03/31/25 End: 12/31/25 Due: 12/31/26

Clinical Trial of the Effect of Methoxyethyl Etomidate Hydrochloride on the QT Interval of the Heart

Phase: N/A Priority: Normal
NCT ID: NCT06822153 Org: User:
Start: 11/09/23 End: 11/21/23 Due: 11/21/24

A Trial to Evaluate the Efficacy and Safety of Methoxyethyl Etomidate Hydrochloride in Gastroscopy/Colonoscopy

Phase: N/A Priority: Normal
NCT ID: NCT06682546 Org: User:
Start: 11/15/24 End: 12/27/24 Due: 12/27/25